Suppression of Diurnal (9AM–4PM) IOP Fluctuations with Minimally Invasive Glaucoma Surgery: An Analysis of Data from the Prospective, Multicenter, Single-Arm GEMINI Study

References

• Spaeth GL, Lopes JF, Junk AK, Grigorian AP, Henderer J. Systems for staging the amount of optic nerve damage in glaucoma: a critical review and new material. Surv Ophthalmol. 2006;51(4):293–315. doi:10.1016/j.survophthal.2006.04.008
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/S0002-9394(00)00538-9
   PubMed Web of Science ®Google Scholar
• Zeimer RC, Wilensky JT, Gieser DK, Viana MA. Association between intraocular pressure peaks and progression of visual field loss. Ophthalmology. 1991;98(1):64–69. doi:10.1016/S0161-6420(91)32340-6
   PubMed Web of Science ®Google Scholar
• De Venecia G, Davis MD. Diurnal variation of intraocular pressure in the normal eye. Arch Ophthalmol. 1963;69:752–757. doi:10.1001/archopht.1963.00960040758013
   Google Scholar
• Drance SM. The significance of the diurnal phasic variation of intraocular pressure in normal and glaucomatous eyes. Trans Can Opthalmolog Soc. 1960;23:131–140.
   Google Scholar
• Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9(2):134–142. doi:10.1097/00061198-200004000-00002
   PubMed Web of Science ®Google Scholar
• Kim JH, Rabiolo A, Morales E, et al. Risk factors for fast visual field progression in glaucoma. Am J Ophthalmol. 2019;207:268–278. doi:10.1016/j.ajo.2019.06.019
   PubMed Web of Science ®Google Scholar
• Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011;118(9):1766–1773. doi:10.1016/j.ophtha.2011.01.047
   PubMed Web of Science ®Google Scholar
• Caprioli J. Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmol. 2007;125(8):1124–1125. doi:10.1001/archopht.125.8.1124
   Google Scholar
• Dubiner HB, Sircy MD, Landry T, et al. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clin Ther. 2004;26(1):84–91. doi:10.1016/S0149-2918(04)90008-2
   Web of Science ®Google Scholar
• Robin AL, Clark AF, Covert DW, et al. Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation. Am J Ophthalmol. 2009;147(1):45–50.e2. doi:10.1016/j.ajo.2008.07.039
   PubMed Web of Science ®Google Scholar
• Medeiros FA, Walters TR, Kolko M, et al. Phase 3, randomized, 20-month study of bimatoprost implant in open-angle glaucoma and ocular hypertension (ARTEMIS 1). Ophthalmology. 2020;127(12):1627–1641. doi:10.1016/j.ophtha.2020.06.018
   PubMed Web of Science ®Google Scholar
• European Glaucoma Society. European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br J Ophthalmol. 2017;101(6):130–195.
   Web of Science ®Google Scholar
• Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma preferred practice pattern®. Ophthalmology. 2021;128(1):P71–P150.
   PubMed Web of Science ®Google Scholar
• Yang SA, Mitchell W, Hall N, et al. Trends and usage patterns of minimally invasive glaucoma surgery in the United States: IRIS® registry analysis 2013–2018. Ophthalmol Glaucoma. 2021. doi:10.1016/j.ogla.2021.03.012
   Google Scholar
• Gallardo MJ, Sarkisian SR, Vold SD, et al. Canaloplasty and trabeculotomy combined with phacoemulsification in open-angle glaucoma: interim results from the GEMINI study. Clin Ophthalmol. 2021;15:481–489. doi:10.2147/OPTH.S296740
   PubMed Web of Science ®Google Scholar
• Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 1999;117(5):573–583. doi:10.1001/archopht.117.5.573
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48–56. doi:10.1001/archopht.121.1.48
   PubMedGoogle Scholar
• Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107(5):453–464. doi:10.1016/0002-9394(89)90488-1
   PubMed Web of Science ®Google Scholar
• Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41(3):741–748.
   PubMed Web of Science ®Google Scholar
• Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96–104. doi:10.1097/ICU.0b013e32834ff1e7
   PubMed Web of Science ®Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–713; discussion 829–830. doi:10.1001/archopht.120.6.701
   Google Scholar
• Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994;101(10):1651–1656; discussion 7. doi:10.1016/S0161-6420(94)31120-1
   Web of Science ®Google Scholar
• Wax MB, Camras CB, Fiscella RG, Girkin C, Singh K, Weinreb RN. Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure. Am J Ophthalmol. 2002;133(6):S1–10. doi:10.1016/S0002-9394(02)01459-9
   Web of Science ®Google Scholar
• Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999;40(12):2912–2917.
   PubMed Web of Science ®Google Scholar
• Brubaker RF. Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci. 1991;32(13):3145–3166.
   PubMed Web of Science ®Google Scholar
• Toris CB, Zhan G, Fan S, et al. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure. J Glaucoma. 2007;16(2):189–195. doi:10.1097/IJG.0b013e31802fc6d3
   PubMed Web of Science ®Google Scholar
• De Moraes CG, Liebmann JM, Levin LA. Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma. Prog Retin Eye Res. 2017;56:107–147. doi:10.1016/j.preteyeres.2016.10.001
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Kaufman PL. The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci. 2009;50(4):1497–1505. doi:10.1167/iovs.08-2843
   PubMed Web of Science ®Google Scholar